Anrui Bio
安锐生物
Anrui Bio
Biotech/Healthcare
Anrui Biotech is a small-molecule drug discovery and development platform. Its pipeline consists of globally novel, first-in-class small-molecule drugs for autoimmune diseases and cancer.
Latest round: Series B (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-03-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.